The effects of Foeniculum Vulgare Mill on indicators of neonatals health and serum prolactin level

Evaluation of the effects of oral consumption of Foeniculum Vulgare Mill capsule on some indicators of neonatal health and prolactin level in over weight or obese lactating mothers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015072623347N1

Enrollment

Registered

2015-09-27

Start date

2015-08-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention 1: Intervention group:6 capsules of Foeniculum vulgare mill daily(3gram per day) for 30 days. Intervention 2: control group:placebo for 30 days.

Treatment - Drugs

Intervention group:6 capsules of Foeniculum vulgare mill daily(3gram per day) for 30 days

control group:placebo for 30 days

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Exclusive breastfeeding by lactating mothers ;Body mass index 25 and higher(According to the first trimester of pregnancy); term and single Delivery;two to six weeks after delivery;The mother complain about the lack of milk despite correct methods of breastfeeding; mother Age : 18-35;monthly cycle of period is not starting after delivery;Not using hormonal contraception(mini pills) Exclusion criteria:The presence of mental illness;Liver Disease and Cancer;Consumption of dopamine antagonist drugs(Domperidone,Metoclopramide,Phenothiazine);Cessation of breastfeeding For whatever reason;The occurrence of any event during the study period;Dissuasion from participating in the study;Breast surgery and Removal of all or part of the breast or mastectomy;Breast plastic surgery;Babies with special problems that Who can not drink milk(Such as cleft lip or palate);Allergy to carrots, celery or other plants Apiaceae family;Sensitivity to drug;Use of herbal medicines;Squeeze of milk.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum Prolactin Level. Timepoint: before intervention,30 days after intervention. Method of measurement: Elisa kit, Elisa Rider System.	—

Secondary

Measure	Time frame
Height,Weight And Head Circumference. Timepoint: before intervention and 30 days after intervention. Method of measurement: Tape Measure(Meter),Balance.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSareh Saeidjou

Shiraz University of Medical Sciences

s.saeidjou65@gmail.com;stud2471686214@sums.ac.ir+98 71364742518

Outcome results